ArticleFrontiers in pharmacology2026

Niraparib promotes ferroptosis by inhibiting TM4SF1 expression through ALKBH1-mediated 6mA modification in BRCA wild-type ovarian cancer.

Po-Wu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.